Pd50-03 cardiovascular events and prostate cancer diagnoses in men treated with testosterone replacement therapy

The U.S. Food and Drug Administration recently issued a caution that testosterone replacement therapy (TRT) may increase the risk of heart attack and stroke. This was based primarily on studies that had short follow-up and limited duration of treatment. We sought to determine the association of the long-term use of TRT and rates of cardiovascular events, prostate cancer, and overall mortality.

Source: The Journal of Urology - March 28, 2016 Category: Urology & Nephrology Authors: Christopher Wallis, Kirk Lo, Yuna Lee, Yonah Krakowsky, Alaina Garbens, Raj Satkunasivam, Sender Herschorn, Ronald Kodama, Patrick Cheung, Steven Narod, Robert Nam Tags: Sexual Function/Dysfunction: Medical, Hormonal & Non-surgical Therapy II Source Type: research